Gout has become the most common inflammatory arthritis worldwide, with a global prevalence fluctuating between 0.1% and 10%. Meanwhile, chronic kidney disease (CKD) represents a massive global burden, affecting over 850 million people. Long-term, uncontrolled hyperuricemia is a clear independent risk factor that causes and accelerates kidney damage. Patients with gout face a higher risk of developing CKD compared to the general population.
How Uric Acid Crystals Physically Damage the Kidneys Gout’s erosion of the kidneys happens most directly through the physical deposition of urate crystals. When the concentration of uric acid in the blood consistently exceeds normal levels, crystals precipitate and deposit in areas like the renal parenchyma, renal tubules, and renal pelvis. These tiny, sharp crystals can directly block the renal tubules responsible for filtration and excretion, ultimately hindering normal urine production and flow. More severely, these crystals trigger sustained local inflammatory responses and the formation of foreign-body granulomas, leading to the gradual fibrosis of kidney tissues where functional nephrons are replaced by scar tissue. Kidney disease caused directly by urate crystals is known as “uric acid nephropathy” or “gouty nephropathy.”
The Danger of High Uric Acid Concentration However, even before urate crystals form, the high concentration of uric acid in the blood itself is damaging to the endothelial cells of kidney blood vessels. By activating the intrarenal renin-angiotensin-aldosterone system (RAAS), it causes persistent constriction of the small arteries within the kidneys, leaving them in a long-term state of ischemia and hypoxia. Simultaneously, a high uric acid state induces intense oxidative stress and chronic low-grade inflammation, generating large amounts of free radicals that attack glomerular and tubular cells, abnormally activating renal fibroblasts, and accelerating kidney fibrosis. Data indicates that for every 60 μmol/L increase in serum uric acid levels, the risk of developing new-onset CKD increases by approximately 22%.
Compounding Risk Factors Gout patients—especially those with a long disease duration, recurrent attacks, and poorly controlled serum uric acid—have an elevated risk of kidney damage. The presence of tophi typically indicates a massive total uric acid pool in the body and widespread crystal deposition, resulting in a higher likelihood of kidney involvement. When gout coexists with metabolic syndrome components like hypertension, diabetes, and obesity, the damage to the kidneys exhibits a synergistic “1+1>2” effect, sharply accelerating kidney function decline. Conversely, kidney disease also impairs uric acid excretion, inducing hyperuricemia and exacerbating the severity of gout.
Strict Uric Acid Control is Key Facing the dual threat of gout and kidney damage, the cornerstone of treatment lies in strictly controlling serum uric acid levels to meet targets over the long term. This is the most direct and effective measure to protect the kidneys. According to authoritative domestic and international guidelines, the goal of urate-lowering therapy should be more stringent for gout patients, especially those with existing kidney damage. It is generally recommended to keep serum uric acid stably below 360 μmol/L; if tophi have already formed, the goal should be below 300 μmol/L to promote crystal dissolution.
Lifestyle Interventions and Medications To alleviate gout, lifestyle intervention is fundamental.
- Adhere to a low-purine diet, strictly limiting organ meats, thick broths, certain seafood, and high-fructose beverages.
- Ensure adequate hydration with over 2,000 ml of water daily to dilute urine and promote uric acid excretion.
- Completely abstain from alcohol, especially beer and liquor.
- Keep body weight within a healthy range through a balanced diet and regular exercise.
These measures can effectively reduce the body’s metabolic burden and create a favorable working environment for the kidneys. Under a doctor’s guidance, patients may regularly use urate-lowering medications like allopurinol, febuxostat, or benzbromarone.
A Natural Alternative for Systematic Care However, medications can sometimes have adverse effects on the body. If you are looking for a milder, more natural alternative, BISPIT Natural Acid & Joint Comfort Supplement 3310B+ is a natural herbal formula developed based on the concept of “reconditioning the crystal-prone constitution.”
This product carefully selects botanical ingredients like chicory, celery seed, and plantain, which work synergistically on multiple stages of uric acid metabolism: it not only inhibits uric acid production at the source but also promotes its excretion through the dual “kidney-intestine” pathways. Meanwhile, extracts of Panax notoginseng, mulberry leaf, and kudzu root integrated into the formula offer anti-inflammatory and antioxidant benefits. These help alleviate chronic inflammation and oxidative stress triggered by high uric acid, reducing continuous damage to kidney and joint tissues.
Through a phased conditioning system, the product aims to help patients gradually stabilize serum uric acid levels, promote the dissolution of urate crystals, and support the recovery of liver and kidney metabolic functions. It provides a gentler, systematic constitution-conditioning option for those with gout and hyperuricemia, helping achieve metabolic balance and long-term kidney protection.